Uncategorized
Spark Therapeutics announces public offering of common stock
Spark Therapeutics will offer $300 million in shares of common stock, according to a company press release.Underwriters will be granted an option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price for a period of 30 days, the release said.